Leading international agricultural sciences business FMC Corporation launches ENTAZIA bio fungicide, a novel bio fungicide for crop protection, in India.
- ENTAZIA bio fungicide was developed based on a proprietary strain of Bacillus subtilis.
- By activating the crop’s defense system against plant pathogens, ENTAZIATM bio fungicide acts to prevent and control bacterial leaf blight, while staying harmless to natural predators and parasites.
- In India, ENTAZIA bio fungicide is authorized for use on pomegranates, tomatoes, gherkins, cucumbers, capsicums, chiles, watermelons, muskmelon, and okra.
- FMC Corporation sources its ENTAZIA bio fungicide from worldwide facilities, which is cultured in a nutrient-rich liquid and processed into a 2.0% solution which is commercialized.
Read more on this article here.
ENTAZIA is safe for both employees and customers, with a 4-hour REI (Restricted Entry Interval) and a 0-day PHI (Pre-Harvest Interval). Why?
A range of businesses that provide biofungicides are as follows:
- The company Bioworks Inc. manufactures RootShield, a biofungicide that defends plant roots against soilborne infections by colonizing their roots with the fungus Trichoderma harzianum strain T-22.
- Trianum, a biofungicide that comprises Trichoderma harzianum strain T-39 and promotes plant development while inhibiting diseases including Pythium, Rhizoctonia, and Fusarium, is available from Koppert Biological Systems Inc.
- Marrone Bio Innovations Inc. is the company behind Regalia, a biofungicide that produces systemic resistance in plants against bacterial and fungal infections by extracting the leaves of a giant knotweed plant, Reynoutria sachalinensis.
- Bacillus subtilis strain IAB/BS03, which prevents the growth of pathogens including Botrytis, Sclerotinia, and Monilinia, is the source of Fungisei, a biofungicide made by Seipasa SA.
Due to the increased interest in organic and sustainable agriculture, as well as growing awareness of the detrimental effects of chemical pesticides on the environment and public health, the market for biofungicide is expanding quickly.
The size of the worldwide biofungicide market is USD 1.3 billion in 2022 and is expected to increase at a compound annual growth rate (CAGR) of 16.00% to reach USD 4.94 billion by 2032, according to sources.